EU Approval Decision Delay For BMS’s Ozanimod
Company Needed More Time To Answer Questions On New MS Product
BMS should find out mid-2020 whether its new MS drug will be approved in the EU.
BMS should find out mid-2020 whether its new MS drug will be approved in the EU.